Search
Menu
BAE Systems Sensor Solutions - Fairchild - Thermal Imaging Solutions 4/24 LB

Leica Microsystems, CMED Collaborate

Facebook X LinkedIn Email
In vitro diagnostic company China Medical Technologies Inc. (CMED) of Beijing and Leica Biosystems, a division of Leica Microsystems based in Wetzlar, Germany, have established a sales, research and development collaboration to develop and market fluorescence in situ hybridization kits for the Leica Bond system, an automated staining platform. The companies will develop automated solutions for tissue sample tests on HER-2, EGFR and TOP2A genes, which play a role in targeted drug therapy for breast, lung and stomach cancer patients. CMED will sell the kits in China, while Leica will have the...Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: October 2011
    Asia-Pacificautomated FISH kitsBiophotonicsbreast cancer drug therapycancer therapy drugsChinaChina Medical Technologies Inc.CMEDcytologyEGFR geneEuro NewsEuropeFISH kitsGermanyHER-2 genehistopathologyImagingin vitro diagnosticsLeica BiosystemsLeica BONDLeica Microsystemslung cancer drug therapymicroscopesNewsprenatal applicationsstaining platformstomach cancer drug therapytissue sample testsTOP2A gene

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.